Home › Funds › Nantahala Capital Management, LLC › AMRX
Nantahala Capital Management, LLC position in AMRX
AMNEAL PHARMACEUTICALS INC · Health Care
Nantahala Capital Management, LLC reported holding 2,115,749 shares of AMRX (AMNEAL PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$42.6M, representing 1.96% of its reported portfolio and ranking #9 among its reported holdings. Nantahala Capital Management, LLC has disclosed AMRX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Nantahala Capital Management, LLC's AMRX position evolved
Nantahala Capital Management, LLC first disclosed a stake in AMRX in Q3 2023 at 2,212,757 shares (US$9.3M). The position peaked in Q3 2026 at 2,115,749 shares, worth US$42.6M. Across 13 filings, Nantahala Capital Management, LLC increased the stake 7 time(s), trimmed it 4 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 2,115,749 shares valued at US$42.6M — a reduction of -153,002 shares quarter over quarter.. Notable position changes include a 37% increase in Q4 2024 (shares rose 6% over the following quarter), a 42% trim in Q4 2025 (shares fell 1% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 2.21M | $9.34M | New |
| Q4 2023 | 2.33M | $14.17M | Add |
| Q1 2024 | 2.62M | $15.88M | Add |
| Q2 2024 | 2.67M | $16.95M | Add |
| Q3 2024 | 2.67M | $22.21M | Hold |
| Q4 2024 | 3.67M | $29.03M | Add |
| Q1 2025 | 3.81M | $31.92M | Add |
| Q2 2025 | 4.37M | $35.33M | Add |
| Q3 2025 | 4.22M | $42.29M | Reduce |
| Q4 2025 | 2.45M | $30.84M | Reduce |
| Q1 2026 | 2.84M | $35.35M | Add |
| Q2 2026 | 2.27M | $39.27M | Reduce |
| Q3 2026 | 2.12M | $42.61M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About AMRX and 13F data
AMRX (AMNEAL PHARMACEUTICALS INC) is a Health Care company. 44 other funds we track also report a position in AMRX — the largest reported positions include TPG GP A, LLC (US$213.4M), Rubric Capital Management LP (US$176.0M), Westshore Wealth, LLC (US$23.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding AMRX
- TPG GP A, LLC 12.33M sh · $213.41M · Q2 2026
- Rubric Capital Management LP 10.17M sh · $176.02M · Q2 2026
- Westshore Wealth, LLC 1.37M sh · $23.65M · Q2 2026
- BlackBarn Capital Partners LP 1.30M sh · $22.50M · Q2 2026
- Phocas Financial Corp. 819.48K sh · $14.19M · Q2 2026
More on Nantahala Capital Management, LLC
FAQ
How long has Nantahala Capital Management, LLC held AMRX?
Nantahala Capital Management, LLC has disclosed AMRX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Nantahala Capital Management, LLC's current position in AMRX?
As of Q3 2026, Nantahala Capital Management, LLC holds 2.12M shares of AMRX (AMNEAL PHARMACEUTICALS INC), valued at $42.61M, representing 1.96% of its reported portfolio and ranking #9.
Has Nantahala Capital Management, LLC been buying or selling AMRX?
In the latest 13F filing (Q3 2026), Nantahala Capital Management, LLC reduced its position in AMRX. The position peaked in Q3 2026 at 2.12M shares.
Which other funds hold AMRX?
Other major institutional holders of AMRX include TPG GP A, LLC, Rubric Capital Management LP, Westshore Wealth, LLC, among 44 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.